secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001628280-26-030898
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Critical Medical Q1 revenue up 87% to $67.4M; net income $2.4M vs prior loss
--------------------------------------------------------------------------------

- Revenue $67.4M (up 87.4% YoY); net income from cont. ops $2.4M vs loss of $1.6M YoY.
- Adjusted EBITDA $6.4M; gross margin improved to 21.0% from 19.6%.
- Logistics revenue up 32.4% to $47.6M; Clinical segment contributed $19.8M (new).
- Completed bolt-on acquisition of Ohio Valley Perfusion Associates; reiterating full-year 2026 guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000162828026030898/0001628280-26-030898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000162828026030898/srta-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-030898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer